Clarissa Uhlar - Concepedia

Author

Clarissa Uhlar

Also Known As

C J de Boer, C M Uhlar, C Uhlar, C. M. UHLAR, C. M. Uhlar, C. Uhlar, Clarissa M Uhlar, Clarissa M. Uhlar, Clarissa Uhlar, Khan, Imran

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)University of Calgary Levine Cancer Institute Janssen (Belgium)Karolinska University Hospital

About

Clarissa Uhlar is an author at Janssen (United States) specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.6K
2	Health Sciences	4	4	438
3	Natural Sciences	2	2	216
4	Allergy	1	1	60
5	Biochemistry	1	1	151

Clarissa Uhlar

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma Henk M. Lokhorst, Torben Plesner, Jacob P. Laubach, New England Journal of Medicine	2015	1.1K
Teclistamab in Relapsed or Refractory Multiple Myeloma Philippe Moreau, Alfred L. Garfall, Niels W.C.J. van de Donk, New England Journal of Medicine	2022	990
Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma Thierry Façon, Shaji Kumar, Torben Plesner, New England Journal of Medicine	2019	947
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial Sagar Lonial, Brendan M. Weiss, Saad Z. Usmani, The Lancet Hematological MalignancyOncologyDaratumumab MonotherapyImmunologyClinical Trials	2016	842
Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma Saad Z. Usmani, Brendan M. Weiss, Torben Plesner, Blood	2016	399
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial Thierry Façon, Shaji Kumar, Torben Plesner, The Lancet Oncology Hematological MalignancyDexamethasone Versus LenalidomideMedicineHematologyMyeloid Neoplasia	2021	345
Acute phase proteins in salmonids: evolutionary analyses and acute phase response Liselotte E. Jensen, Maura Hiney, Denis C. Shields, The Journal of Immunology	1997	169
Evolution of the Serum Amyloid A (SAA) Protein Superfamily Clarissa Uhlar, Conal J. Burgess, Paul M. Sharp, Genomics BiochemistryProtein FoldingNatural SciencesProtein EvolutionMolecular Biology	1994	151
Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti–IL-6) in multiple myeloma Jesús F. San Miguel, Joan Bladé, Ofer Shpilberg, Blood	2014	138
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA Thierry Façon, Gordon Cook, Saad Z. Usmani, Leukemia	2022	117

Page 1